Online Textbook Bacteriology is continuously updated and includes information on Staphylococcus, MRSA, Streptococcus, pseudomonas, anthrax, E. coli, cholera, tuberculosis, Lyme disease and other bacterial pathogens that cause diseases of humans.
Kenneth Todar is the author of the Online Textbook of Bacteriology and an emeritus lecturer at the University of Wisconsin-Madison.Business and organizations with products and services related to bacteriology PLACE YOUR AD HERE Contact kentodar@textbookofbacteriology.net
The Online Textbook of Bacteriology is about microbes, including staph, MRSA, strep, anthrax, E. coli, salmonella cholera, pneumonia, meningitis, gastroenteritis, tuberculosis, Lyme disease and other bacterial pathogens.
Kenneth Todar, PhDKenneth Todar's Online Textbook of Bacteriology Home PageOnline Textbook of Bacteriology Table of ContentsInformation about materials for teaching bacteriology.Contact Kenneth Todar.







Textbook of Bacteriology
Quick Links:


bacteriology

microbes in the environment

cycles of elements

bacterial structure

bacterial nutrition

bacterial growth

bacterial metabolism

bacteria and archaea

normal flora

bacterial pathogens

bacterial toxins

endotoxin

antibiotics

antibiotic resistance

staphylococci and MRSA

Streptococcus

pneumonia

anthrax

E. coli

cholera

Salmonella

Pseudomonas

Shigella

gonorrhea

meningococcal meningitis

botulism and tetanus

hib meningitis

Listeria

whooping cough

B. cereus food poisoning

tuberculosis

diphtheria

Rocky Mountain spotted fever

Lyme disease

Vibrio vulnificus

Bacillus

lactic acid bacteria














Kenneth Todar currently teaches Microbiology 100 at the University of Wisconsin-Madison.  His main teaching interest include general microbiology, bacterial diversity, microbial ecology and pathogenic bacteriology.

 Print this Page

MRSA Methicillin-Resistant Staphylococcus aureus

© Kenneth Todar, PhD


Staphylococcus aureus


Staphylococcus aureus is the quintessential superbug. Hospital strains of Staphylococcus aureus are usually resistant to a variety of different antibiotics. A few strains are resistant to all clinically useful antibiotics except vancomycin, and vancomycin-resistant strains are increasingly-reported. The term MRSA refers to Methicillin resistant Staphylococcus aureus. Methicillin resistance is widespread and most methicillin-resistant strains are also multiply drug-resistant. In addition, S. aureus exhibits resistance to antiseptics and disinfectants, such as quaternary ammonium compounds, which may aid its survival in the hospital environment.

Staphylococcal disease has been a perennial problem in the hospital environment since the beginning of the antibiotic era. During the 1950's and early 1960's, staphylococcal infection was synonymous with nosocomial infection. Gram-negative bacilli (e.g. E. coli and Pseudomonas aeruginosa) have replaced staph as the most frequent causes of nosocomial infections, although the staphylococci have remained a problem, especially in surgical wounds. S aureus responded to the introduction of antibiotics by the usual bacterial means to develop drug resistance: (1) mutation in chromosomal genes followed by selection of resistant strains and (2) acquisition of resistance genes as extrachromosomal plasmids, transducing particles, transposons, or other types of DNA inserts. S. aureus expresses its resistance to drugs and antibiotics through a variety of mechanisms.

MRSA

MRSA are strains of the Staphylococcus aureus that are resistant to the action of methicillin and related beta-lactam antibiotics (e.g. penicillin, oxacillin, amoxacillin). MRSA have evolved resistance not only to beta-lactam antibiotics, but to several classes of antibiotics. Some MRSA are resistant to all but one or two antibiotics, including vancomycin. Reports of VRSA (Vancomycin-Resistant Staph aureus) or VRSA are troublesome in the ongoing battle against staph infections.

MRSA are often sub-categorized as Hospital-Associated MRSA (HA-MRSA) or Community-Associated MRSA (CA-MRSA), depending upon the circumstances of acquiring disease. Based on current data, these are distinct strains of the bacterial species.

HA-MRSA occurs most frequently among patients who undergo invasive medical procedures or who have weakened immune systems and are being treated in hospitals and healthcare facilities such as nursing homes and dialysis centers. MRSA in healthcare settings commonly causes serious and potentially life threatening infections, such as bloodstream infections, surgical site infections or pneumonia.

In the case of HA-MRSA, patients who already have an MRSA infection or who carry the bacteria on their bodies but do not have symptoms (are colonized) are the most common sources of transmission. The main mode of transmission to other patients is through human hands, especially healthcare workers' hands. Hands may become contaminated with MRSA bacteria by contact with infected or colonized patients. If appropriate hand hygiene such as washing with soap and water or using an alcohol-based hand sanitizer is not performed, the bacteria can be spread when the healthcare worker touches other patients.

MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are categorized as community-associated (CA-MRSA) infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions.

About 75 percent of CA-MRSA infections are localized to skin and soft tissue and usually can be treated effectively. However, CA-MRSA strains display enhanced virulence, spread more rapidly and cause more severe illness than traditional HA-MRSA infections, and can affect vital organs leading to widespread infection (sepsis), toxic shock syndrome and pneumonia. It is not known why some healthy people develop CA-MRSA skin infections that are treatable whereas others infected with the same strain develop severe, fatal infections.

Studies have shown that rates of CA-MRSA infection are growing fast. In 1999, four children in Minnesota and North Dakota were reported to have died from fulminant CA-MRSA infections One study of children in south Texas found that cases of CA-MRSA increased 14-fold between 1999 and 2001. By 2007, CA-MRSA was the most frequent cause of skin and soft-tissue infections seen in emergency departments in the United States.

Although most MRSA cases are skin and soft-tissue infections, some are more serious with septicemia and pneumonia. It was reported in 2005 that previously healthy adolescents without any predisposing risk factors presented more frequently with severe Staph infections (mostly the USA 300 strain) since 2002.

CA-MRSA skin infections have been identified among certain populations that share close quarters or experience more skin-to-skin contact. Examples are team athletes, military recruits, and prisoners. However, more and more, CA-MRSA infections are being seen in the general community as well, especially in certain geographic regions.

Also, CA-MRSA are infecting much younger people. In a study of Minnesotans published in The Journal of the American Medical Association, the average age of people with MRSA in a hospital or healthcare facility was 68. But the average age of a person with CA-MRSA was only 23.

In the United States it is estimated that 31.8 out of 100,000 people are being infected by MRSA each year, more infections than meningitis, bacterial pneumonia and flesh-eating strep put together. More people in the U.S. now die from MRSA infection than from AIDS. Methicillin-resistant Staphylococcus aureus was responsible for an estimated 94,000 life-threatening infections and 18,650 deaths in 2005, as reported by CDC in the Oct. 17, 2007 issue of The Journal of the American Medical Association. The national estimate is more than double the invasive MRSA prevalence reported five years earlier. That same year, roughly 16,000 people in the U.S. died from AIDS, according to CDC.

While most invasive MRSA infections could be traced to a hospital stay or some other health care exposure, about 15% of invasive infections occurred in people with no known health care risk. Two-thirds of the 85% of MRSA infections that could be traced to hospital stays or other health care exposures occurred among people who were no longer hospitalized. People over age 65 were four times more likely than the general population to get an MRSA infection. Incidence rates among blacks were twice that of the general population, and rates were lowest among children over the age of 4 and teens.

MRSA Statistics

In 2010, encouraging results from a CDC study published in the Journal of the American Medical Association showed that invasive (life-threatening) MRSA infections in healthcare settings are declining. Invasive MRSA infections that began in hospitals declined 28% from 2005 through 2008. Decreases in infection rates were even bigger for patients with bloodstream infections. In addition, the study showed a 17% drop in invasive MRSA infections that were diagnosed before hospital admissions (community onset) in people with recent exposures to healthcare settings.

A parallel study from the National Healthcare Safety Network (NHSN) found that rates of MRSA bloodstream infections occurring in hospitalized patients fell nearly 50% from 1997 to 2007. Furthermore, a March 2011, CDC Vital Signs article reported that bloodstream infections from staph in ICU patients with central lines were reduced by 73%, more than from any other cause.

Taken altogether these reports provide evidence that rates of invasive MRSA infections in the United States are falling. While MRSA remains an important public health problem and more remains to be done to further decrease risks of developing these infections, this decrease in healthcare-associated MRSA infections is encouraging.

On the other hand, rates of CA-MRSA infections have increased rapidly during the past decade and there is little evidence that the risk of developing infection is following the same downward trend as HA-MRSA.

Outlook

Beginning with the use of the penicillin in the 1940's, drug resistance has developed in the staphylococci within a very short time after introduction of an antibiotic into clinical use. Some strains are now resistant to most conventional antibiotics, and there is concern that new antibiotics have not been forthcoming. New strategies in the pharmaceutical industry to find antimicrobial drugs involve identifying potential molecular targets in cells (such as the active sites of enzymes involved in cell division), then developing inhibitors of the specific target molecule. Hopefully, this approach will turn up new antimicrobial agents for the battle against staph infections. Indeed, since 2003, alternatives to vancomycin have been approved for treatment of MRSA.




Textbook of Bacteriology Index






© Kenneth Todar, Ph.D. All rights reserved. - www.textbookofbacteriology.net



Kenneth Todar, PhD | Home | Table of Contents | Lecture Aids | Contact | Donate

Kenneth Todar has taught microbiology to undergraduate students at The University of Texas, University of Alaska and University of Wisconsin since 1969.

© 2008-2012 Kenneth Todar, PhD - Madison, Wisconsin